Understanding How Adempas Works — Without the Medical Jargon

Your doctor prescribed Adempas (Riociguat) and maybe mentioned something about "soluble guanylate cyclase" or "cGMP." If your eyes glazed over, you're not alone. The science behind Adempas is fascinating but can sound intimidating.

Here's the thing: understanding how your medication works can actually help you take it more effectively and recognize why certain side effects happen. So let's break down the mechanism of action of Adempas in plain English.

The Problem Adempas Solves

In pulmonary hypertension — whether it's PAH (pulmonary arterial hypertension) or CTEPH (chronic thromboembolic pulmonary hypertension) — the arteries in your lungs become narrowed, stiff, or blocked. This forces your heart's right ventricle to pump harder to push blood through those narrowed vessels.

Over time, this extra strain weakens the heart. Meanwhile, the narrowed arteries mean less oxygen gets exchanged efficiently, leaving you short of breath, fatigued, and limited in what you can do physically.

Adempas addresses this by relaxing and widening those pulmonary blood vessels, reducing the pressure and making it easier for blood to flow through your lungs.

What Adempas Does in Your Body

Here's the step-by-step process, simplified:

Step 1: It Targets an Enzyme Called sGC

Inside the walls of your blood vessels, there's an enzyme called soluble guanylate cyclase (sGC). Think of sGC as a switch that, when activated, tells your blood vessels to relax. In healthy people, this switch is activated by nitric oxide (NO) — a natural molecule your body produces.

In pulmonary hypertension, this nitric oxide signaling pathway is impaired. Your body may not produce enough nitric oxide, or the sGC enzyme may not respond to it as well as it should.

Step 2: Adempas Stimulates sGC Directly

This is what makes Adempas unique. It works in two ways:

1. It directly stimulates sGC — even without nitric oxide present. This means it can activate the "relax" signal even when your body's natural nitric oxide levels are low
2. It makes sGC more sensitive to whatever nitric oxide is available — amplifying the signal your body is already trying to send

This dual action is why Adempas is classified as an sGC stimulator rather than just working through nitric oxide alone.

Step 3: Activated sGC Produces cGMP

When sGC is stimulated (whether by Adempas, nitric oxide, or both), it converts a molecule called GTP into cGMP (cyclic guanosine monophosphate). Think of cGMP as the actual messenger that tells the blood vessel muscles to relax.

Step 4: cGMP Relaxes the Blood Vessels

The increased cGMP causes the smooth muscle cells in your pulmonary artery walls to relax and dilate (widen). This is called vasodilation. When the blood vessels open up, blood flows through more easily, the pressure drops, and your heart doesn't have to work as hard.

Additionally, cGMP may help prevent the blood vessel walls from thickening and stiffening further — a process called vascular remodeling — which is part of what makes pulmonary hypertension progressive.

How Long Does Adempas Take to Work?

Adempas starts working relatively quickly in your body after each dose:

• Peak blood levels: Adempas reaches its highest concentration in your blood about 1 to 1.5 hours after you take it
• Noticeable clinical improvement: You may start to notice improvements in your symptoms (less shortness of breath, better exercise tolerance) within the first few weeks of treatment, though the full benefit often takes 8-12 weeks as your dose is titrated up to the optimal level
• Clinical trial results: In the major clinical trials (CHEST-1 for CTEPH and PATENT-1 for PAH), significant improvements in exercise capacity (measured by the 6-minute walk test) were seen at 16 weeks

It's important to be patient during the titration period. Your doctor will increase your dose gradually every 2 weeks, and the full benefit comes at the maintenance dose of 2.5 mg three times daily (for most patients). For details on dosing, see our guide on Adempas uses and dosage.

How Long Does Each Dose Last?

Adempas has a half-life of about 7-12 hours in most patients. The half-life is the time it takes for the amount of drug in your blood to decrease by half. This is why Adempas is taken three times daily — to maintain consistent levels throughout the day.

If you miss a dose, the drug levels in your blood will drop, which is why it's important to take Adempas on a regular schedule. If you miss a dose, take it as soon as you remember, but don't double up.

What Makes Adempas Different From Other PH Medications?

There are several classes of medications used to treat pulmonary hypertension. Understanding how they differ can help you appreciate why your doctor chose Adempas — and why certain combinations are safe while others are dangerous.

Adempas vs. PDE-5 Inhibitors (Sildenafil, Tadalafil)

PDE-5 inhibitors like Sildenafil (Revatio) and Tadalafil (Adcirca) are commonly used for PAH. They work on a different part of the same pathway:

• Adempas works upstream — it stimulates sGC to produce more cGMP
• PDE-5 inhibitors work downstream — they prevent the breakdown of cGMP by blocking an enzyme called phosphodiesterase-5

Both increase cGMP levels, but through different mechanisms. This is exactly why they cannot be combined — taking both would cause cGMP levels to skyrocket, leading to dangerously low blood pressure. Adempas and PDE-5 inhibitors are contraindicated together. Read more in our drug interactions guide.

Adempas vs. Endothelin Receptor Antagonists (ERAs)

ERAs like Bosentan (Tracleer), Ambrisentan (Letairis), and Macitentan (Opsumit) work on an entirely different pathway. They block a substance called endothelin-1, which causes blood vessels to constrict. By blocking this signal, ERAs help blood vessels relax.

Because ERAs work on a different pathway, they can be safely combined with Adempas. Many PAH patients take both an ERA and Adempas as part of combination therapy.

Adempas vs. Prostacyclin Pathway Therapies

Medications like Treprostinil (Remodulin, Orenitram, Tyvaso) and Selexipag (Uptravi) work through the prostacyclin pathway — yet another separate mechanism that relaxes blood vessels and prevents clotting. These can also be combined with Adempas in appropriate patients.

Why Adempas Is Unique

Adempas occupies a unique position because:

• It's the only sGC stimulator on the market
• It's the only FDA-approved medication for inoperable/persistent CTEPH
• It has a dual mechanism (direct stimulation + nitric oxide sensitization)
• It can be combined with ERAs and prostacyclin therapies but never with PDE-5 inhibitors or nitrates

For a comparison of all treatment options, see our guide on alternatives to Adempas.

Final Thoughts

Adempas works by stimulating an enzyme (sGC) in your blood vessel walls, which produces a messenger molecule (cGMP) that tells those vessels to relax. The result: lower pressure in your pulmonary arteries, less strain on your heart, and improved ability to be active.

What makes it special is its dual action — it can work even when your body's natural nitric oxide levels are low, and it amplifies whatever nitric oxide signal is present. This mechanism is distinct from PDE-5 inhibitors (which is why they can't be combined) and from ERAs and prostacyclin therapies (which is why those combinations are safe).

Understanding how your medication works empowers you to take it correctly, recognize side effects for what they are, and have more informed conversations with your doctor. For more practical information, check out our guides on Adempas side effects and saving money on Adempas. And if you need help finding a pharmacy, Medfinder can help.